Table 2.
Genetic alteration | Signature of DNA methylation patterns | Suggested mechanism of aberrant DNA methylation induction in AML |
---|---|---|
PML-RARa t(15;17) |
Accentuated hypermethylation and hypomethylation. | PML-RARa suggested to recruit DNMTs to binding site causing DNA hypermethylation. Secondary epigenetic dysregulation as PML-RARa binds to genomic regions of epigenetic modifiers including DNMT3A. |
AML1/ETO t(8;21) |
Accentuated hypermethylation and hypomethylation. Though predominantly hypomethylation. |
Unclear mechanism AML1/ETO may recruit DNMT1 and HDAC1. Possibly works through secondary DNA methylation disruption of AML1-ETO target genes. |
CBFb-MYH11 inv(16)— t(16;16) |
Predominantly hypomethylation. | Unclear mechanism. |
TET2 mutations | Hypermethylation signature. | Mutated TET2 is impaired in its hydroxymethylation capacity. Unclear if DNA hypermethylated genes are direct TET2 target genes. |
IDH1/2 mutations |
Pronounced genome wide hypermethylation signature. | Possibly via IDH (isocitrate dehydrogenase) mutations result in DNA hypermethylation via inhibition of α-ketoglutarate dependent dioxygenases (e.g., TET2). |
DNMT3A mutations |
Genome-wide DNA hypomethylation signature: studies give mixed findings. | Mechanism of aberrant DNA methylation induction unclear. In vitro mechanism may be through loss of catalytic activity via R882H mutation. Unclear in vivo mechanism. |
MLL-translocation -(11q23) | Pronounced DNA hypomethylation signature. | Unclear mechanism. |
CEBPα mutations |
Two patterns of hypomethylated and hypermethylated sites depending on the detection method used. | Unclear mechanism. |
RUNX1 mutations |
Discrete hypermethylation and hypomethylation signature. | Unclear mechanism. |
NPM1 mutations |
Mixed hypermethylation and hypomethylation pattern. Strong hypomethylation in some studies. | Unclear mechanism. |